US 9399674
Human antibodies to Clostridium difficile toxins
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9399674 (Human antibodies to Clostridium difficile toxins) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/40, A61P